Variscite NY Four, LLC v. New York State Cannabis Control Board

CourtDistrict Court, N.D. New York
DecidedFebruary 2, 2024
Docket1:23-cv-01599
StatusUnknown

This text of Variscite NY Four, LLC v. New York State Cannabis Control Board (Variscite NY Four, LLC v. New York State Cannabis Control Board) is published on Counsel Stack Legal Research, covering District Court, N.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Variscite NY Four, LLC v. New York State Cannabis Control Board, (N.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF NEW YORK

VARISCITE NY FOUR, LLC AND VARISCITE NY FIVE, LLC,

Plaintiffs, 1:23-cv-01599 (AMN/CFH) v.

NEW YORK STATE CANNABIS CONTROL BOARD; NEW YORK STATE OFFICE OF CANNABIS MANAGEMENT; TREMAINE WRIGHT; AND CHRIS ALEXANDER,

Defendants.

APPEARANCES: OF COUNSEL:

JEFFREY M. JENSEN JEFFREY M. JENSEN, ESQ. 9903 Santa Monica Blvd. # 890 Pro Hac Vice Beverly Hills, CA 90212 Attorney for Plaintiffs

E. STEWART JONES HACKER MURPHY, LLP THOMAS J. HIGGS, ESQ. 28 Second Street-Suite 203 Troy, NY 12180 Attorneys for Plaintiffs

HON. LETITIA JAMES RYAN W. HICKEY, ESQ. New York State Attorney General Assistant Attorney General The Capitol Albany, NY 12224 Attorney for Defendants Hon. Anne M. Nardacci, United States District Judge: MEMORANDUM-DECISION AND ORDER I. INTRODUCTION Plaintiffs Variscite NY Four, LLC and Variscite NY Five, LLC (“Plaintiffs”) commenced this action on December 18, 2023 against Defendants New York State Cannabis Control Board (the “Board”), New York State Office of Cannabis Management (“OCM” or the “Office”), Tremaine Wright, and Chris Alexander (collectively “Defendants”), pursuant to 42 U.S.C. § 1983. See Dkt. No. 11 (the “Complaint”).2 Plaintiffs allege that New York’s Adult Use Application Program, which accepted applications for adult use retail dispensary cannabis licenses (“Adult Use Licenses”) from October 4, 2023 through December 18, 2023 (the “Adult Use Application

Program”), violates the dormant Commerce Clause. See generally id. On December 21, 2023, Plaintiffs filed a motion by order to show cause for a temporary restraining order and preliminary injunction seeking to enjoin Defendants from issuing Adult Use Licenses or issuing any additional licenses under the CAURD Application Program. See Dkt. Nos. 10-12 (the “Motion”). On December 28, 2023, Defendants submitted a Letter Brief opposing the Motion. Dkt. No. 16.3 On January 9, 2024, the Court directed expedited briefing on the Motion, and on January 16, 2024, Defendants filed an Opposition, Dkt. Nos. 25-29.4 On January 26, 2024, the Court held a hearing on the Motion (the “Motion Hearing”).5

1 Citations to court documents utilize the pagination generated by CM/ECF, the Court’s electronic filing system. 2 The Complaint also alleges that Defendants violated Section 10(19) of New York’s Marihuana Regulation & Taxation Act (“Cannabis Law”), which provides that “the initial adult-use cannabis retail dispensary license application period shall be opened for all applicants at the same time,” see NY CANBS. § 10(19), when Defendants opened “applications only from a certain subcategory of applicants called Conditional Adult Use Retail Dispensary (“CAURD”) applicants from August 25, 2022, through September 26, 2022” (the “CAURD Application Program”) before opening the Adult Use Application Program. Dkt. No. 1 at ¶¶ 34-47. Plaintiffs do not assert a cause of action related to the CAURD Application Program. Id. at ¶¶ 48-57. 3 On January 3, 2024, this matter was reassigned from United States District Judge David N. Hurd to the undersigned. See Dkt. No. 19. 4At that time, Defendants also filed a Motion to Dismiss for failure to state a claim and for lack of subject matter jurisdiction, see Dkt. No. 30, which is not ripe for review because it has not been fully briefed by the parties. 5 On February 1, 2024, Defendants submitted a Supplemental Declaration in Support of Defendants’ Opposition, Dkt. No. 34, and on February 2, 2024, Plaintiffs filed a Response, Dkt. For the reasons set forth herein, the Court denies Plaintiffs’ Motion for a temporary restraining order and a preliminary injunction. II. BACKGROUND A. Legality of Cannabis under Federal Law Under the Controlled Substances Act (“CSA”), it is unlawful “to manufacture, distribute,

or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance,” including cannabis. 21 U.S.C. § 841(a)(1); see 21 U.S.C. § 812(c) (classifying cannabis as a Schedule I controlled substance). However, as to the use of cannabis for certain medical conditions, Congress has prohibited the Department of Justice (“DOJ”) from using funds “to prevent any [state] from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.” See Consolidated Appropriations Act of 2022, Pub. L. No. 117-103, 136 Stat. 49, § 530 (2022) (the “Rohrabacher-Farr Amendment”); see also Brinkmeyer v. Wash. State Liquor & Cannabis Bd., No. C20-5661 BHS, 2023 WL 1798173, at *2 (W.D. Wash. Feb. 7, 2023) (noting that in “each fiscal year since fiscal year 2015, Congress has

prohibited the [DOJ] from using its appropriated funds to take legal action against states that have implemented laws legalizing medicinal marijuana”), appeal dismissed, No. 23-35162, 2023 WL 3884102 (9th Cir. Apr. 11, 2023).6 On the other hand, Congress “has not amended the CSA to legalize marijuana for either medical or recreational use.” Ne. Patients Grp. v. Me. Dep’t of Admin.

No. 35. 6 In 2013, U.S. Deputy Attorney General James Cole issued a memorandum entitled “Guidance Regarding Marijuana Enforcement” (the “Cole Memo”), encouraging “prosecutorial discretion in enforcing federal marijuana laws in states where [medicinal marijuana] had been legalized” and which have a “strong and effective state regulatory system.” Brinkmeyer, 2023 WL 1798173, at *2; Peridot Tree WA Inc. v. Wash. State Liquor & Cannabis Control Bd., No. 3:23-CV-06111- TMC, 2024 WL 69733, at *1 (W.D. Wash. Jan. 5, 2024). The Cole Memo was rescinded in 2018 by Attorney General Jeff Sessions. Brinkmeyer, 2023 WL 1798173, at *2. & Fin. Servs., 554 F. Supp. 3d 177, 182 (D. Me. 2021), aff’d sub nom. Ne. Patients Grp. v. United Cannabis Patients & Caregivers of Me., 45 F.4th 542 (1st Cir. 2022). B. New York Cannabis Law In 2021, the New York Legislature determined that existing marihuana laws had “resulted in devastating collateral consequences including mass incarceration and other complex

generational trauma, that inhibit an otherwise law-abiding citizen’s ability to access housing, employment opportunities, and other vital services.” N.Y. CANBS. § 2. To address these collateral consequences and for various other purposes, on March 31, 2021, New York enacted the Marihuana Regulation & Taxation Act (“MRTA”), with the short title of “Cannabis Law.” N.Y. CANBS. § 1.7 Article II of the Cannabis Law establishes the OCM8 and the Board,9 which are responsible for implementing and enforcing the Cannabis Law in New York. N.Y. CANBS. §§ 7- 11. Additionally, the Cannabis Law legalizes adult use cannabis and regulates its production, manufacturing, distribution, and sale in New York. See N.Y. CANBS. §§ 3, 61-89; see also N.Y.

7 “The intent of [the MRTA] is to regulate, control, and tax marihuana. . . generate significant new revenue, make substantial investments in communities and people most impacted by cannabis criminalization to address the collateral consequences of such criminalization, prevent access to cannabis by those under the age of twenty-one years, reduce the illegal drug market and reduce violent crime, reduce participation of otherwise law-abiding citizens in the illicit market, end the racially disparate impact of existing cannabis laws, create new industries, protect the environment, improve the state’s resiliency to climate change, protect the public health, safety and welfare of the people of the state, increase employment and strengthen New York’s agriculture sector.” NY CANBS. § 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

New Energy Co. of Indiana v. Limbach
486 U.S. 269 (Supreme Court, 1988)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
General Motors Corp. v. Tracy
519 U.S. 278 (Supreme Court, 1997)
Department of Revenue of Kentucky v. Davis
553 U.S. 328 (Supreme Court, 2008)
Nken v. Holder
556 U.S. 418 (Supreme Court, 2009)
Jsg Trading Corp. v. Tray-Wrap, Inc.
917 F.2d 75 (Second Circuit, 1990)
Sussman v. Crawford
488 F.3d 136 (Second Circuit, 2007)
Mazurek v. Armstrong
520 U.S. 968 (Supreme Court, 1997)
Faiveley Transport Malmo AB v. Wabtec Corp.
559 F.3d 110 (Second Circuit, 2009)
AYCO COMPANY, LP v. Frisch
795 F. Supp. 2d 193 (N.D. New York, 2011)
325 Bleecker, Inc. v. Local Union No. 747
500 F. Supp. 2d 110 (N.D. New York, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Variscite NY Four, LLC v. New York State Cannabis Control Board, Counsel Stack Legal Research, https://law.counselstack.com/opinion/variscite-ny-four-llc-v-new-york-state-cannabis-control-board-nynd-2024.